{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:04:16Z","timestamp":1791011056300,"version":"4.1.0"},"reference-count":39,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,8,24]],"date-time":"2009-08-24T00:00:00Z","timestamp":1251072000000},"content-version":"vor","delay-in-days":54,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Dialysis"],"published-print":{"date-parts":[[2009,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Neurological and vascular impairment are important sources of morbidity in patients with renal failure. A portion of patients still suffers from uremic encephalopathy or other signs of nervous system impairment. Several reports demonstrate increased incidence of cardiac infarction and cerebrovascular accidents in chronic renal failure patients, even in those otherwise adequately dialyzed. Epileptic and cognitive symptoms are among the most typical manifestations of uremic encephalopathy. Several guanidino compounds (GCs) may play an important role in the etiology of uremic encephalopathy. Four GCs appeared to be substantially increased as well in serum, cerebrospinal fluid, and brain of uremic patients. These compounds, \u201curemic\u201d GCs, are creatinine, guanidine (G), guanidinosuccinic acid (GSA), and methylguanidine. All four compounds are experimental convulsants in concentrations similar to those found in uremic brain. We described a possible mechanism for the contribution of GCs to uremic hyperexcitability, referring to the in vitro effects of uremic GCs on inhibitory and excitatory amino acid receptors. It was demonstrated that the excitatory effects of uremic GCs on the central nervous system can be explained by the activation of <jats:italic>N<\/jats:italic>\u2010methyl\u2010<jats:sc>d<\/jats:sc>\u2010aspartate receptors by GSA, concomitant inhibition of \u03b3\u2010aminobutyric acid type A receptors by uremic GCs, and other depolarizing effects. These effects might also indicate the putative contribution of uremic GCs to the etiology of uremic encephalopathy. In this article, we review the uremic GCs with particular attention to their neurotoxicity. We elaborate in detail on the mechanisms of action of the neurotoxic uremic GCs and summarize the kinetics of these toxins.<\/jats:p>","DOI":"10.1111\/j.1525-139x.2009.00577.x","type":"journal-article","created":{"date-parts":[[2009,8,24]],"date-time":"2009-08-24T07:59:31Z","timestamp":1251100771000},"page":"340-345","source":"Crossref","is-referenced-by-count":127,"title":["PROGRESS IN UREMIC TOXIN RESEARCH: Guanidino Compounds as Uremic (Neuro)Toxins"],"prefix":"10.1111","volume":"22","author":[{"given":"Peter Paul","family":"De Deyn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Vanholder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunny","family":"Eloot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Griet","family":"Glorieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,8,24]]},"reference":[{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2004.07.012"},{"key":"e_1_2_10_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(87)90088-X"},{"key":"e_1_2_10_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-0186(95)00041-6"},{"key":"e_1_2_10_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(86)90220-2"},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.1159\/000184166"},{"key":"e_1_2_10_7_2","first-page":"141","article-title":"Evidence that guanidines and some related compounds cause haemolysis in chronic uraemia","volume":"34","author":"Giovannetti S","year":"1968","journal-title":"Clin Sci"},{"key":"e_1_2_10_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196904242801704"},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.63.s84.43.x"},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.59780077.x"},{"key":"e_1_2_10_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(97)90273-0"},{"key":"e_1_2_10_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.2009.00593.x"},{"key":"e_1_2_10_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.2009.00578.x"},{"key":"e_1_2_10_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)07217-8"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00631.x"},{"key":"e_1_2_10_16_2","article-title":"Role of symmetric dimethylarginine in vascular damage by increasing ROS production via store\u2010operated calcium\u2010influx in monocytes","author":"Schepers E","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000141041.71717.11"},{"key":"e_1_2_10_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2004.02.021"},{"key":"e_1_2_10_19_2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1182\/blood.V30.3.331.331","article-title":"Defective ADP\u2010induced platelet factor 3 activation in uremia","volume":"30","author":"Horowitz HI","year":"1967","journal-title":"Blood"},{"key":"e_1_2_10_20_2","first-page":"397","article-title":"Guanidinosuccinic acid: the \u201cX\u201d factor in uremic bleeding?","volume":"16","author":"Stein IM","year":"1968","journal-title":"Clin Res"},{"key":"e_1_2_10_21_2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/archinte.1973.00320110093014","article-title":"Methylguanidine in uremia","volume":"131","author":"Giovannetti S","year":"1973","journal-title":"Arch Intern Med"},{"key":"e_1_2_10_22_2","first-page":"445","article-title":"Uremia\u2010like syndrome in dogs chronically intoxicated with methylguanidine and creatinine","volume":"36","author":"Giovannetti S","year":"1969","journal-title":"Clin Sci"},{"key":"e_1_2_10_23_2","first-page":"65","article-title":"Convulsive activity of methylguanidine in cat and rabbits","volume":"4","author":"Matsumoto M","year":"1976","journal-title":"IRCS Med Sci"},{"key":"e_1_2_10_24_2","first-page":"3668","article-title":"Biochemical and physiological studies on guanidino compounds induced convulsions","volume":"106","author":"Jinnai D","year":"1969","journal-title":"Jpn J Brain Physiol"},{"key":"e_1_2_10_25_2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF02734659","article-title":"Biochemistry and neurotoxicology of guanidino compounds. History and recent advances","volume":"22","author":"Mori A","year":"1987","journal-title":"Pav J Biol Sci"},{"key":"e_1_2_10_26_2","first-page":"295","article-title":"The effects of homoarginine on the EEG of rats","volume":"2","author":"Yokoi I","year":"1984","journal-title":"Neurochem Pathol"},{"key":"e_1_2_10_27_2","first-page":"71","article-title":"Inhibition of brain sodium\u2010potassium ATPase in uremic rats","volume":"80","author":"Minkoff L","year":"1972","journal-title":"J Lab Clin Med"},{"key":"e_1_2_10_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(92)90138-B"},{"key":"e_1_2_10_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(92)90200-S"},{"key":"e_1_2_10_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410280505"},{"key":"e_1_2_10_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(99)00190-1"},{"key":"e_1_2_10_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(93)90718-Z"},{"key":"e_1_2_10_33_2","first-page":"441","volume-title":"Guanidino Compounds in Biology and Medicine","author":"Reynolds IJ","year":"1992"},{"key":"e_1_2_10_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(96)00011-1"},{"key":"e_1_2_10_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410300419"},{"key":"e_1_2_10_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(96)12615-X"},{"key":"e_1_2_10_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2004.12.001"},{"key":"e_1_2_10_38_2","first-page":"143","article-title":"Excitatory amino acid receptors in the vertebrate central nervous system","volume":"40","author":"Collingridge GL","year":"1989","journal-title":"Pharmacol Rev"},{"key":"e_1_2_10_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00238.x"},{"key":"e_1_2_10_40_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2007.05.009"}],"container-title":["Seminars in Dialysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1525-139X.2009.00577.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1525-139X.2009.00577.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T08:26:32Z","timestamp":1697099192000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1525-139X.2009.00577.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["10.1111\/j.1525-139X.2009.00577.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1525-139x.2009.00577.x","archive":["Portico"],"relation":{},"ISSN":["0894-0959","1525-139X"],"issn-type":[{"value":"0894-0959","type":"print"},{"value":"1525-139X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}